Meridian Bioscience | VIVO - Ebitda

Meridian Bioscience reported $13.03M in EBITDA for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ebitda Change
Abbott ABT:US USD 2.13B 454M
Accelerate Diagnostics AXDX:US USD -14189000 2.98M
Atrion ATRI:US USD 12.28M 2.2M
Becton, Dickinson and BDX:US USD 1.24B 11M
Bio Rad Laboratories BIO:US USD 125.04M 5.05M
Cerus CERS:US USD -9302000 2.56M
Myriad Genetics MYGN:US USD -32300000 400K
Neogen NEOG:US USD 44.48M 18.99M
Orasure Technologies OSUR:US USD 17.2M 5.84M
Quidel QDEL:US USD 166.8M 20.6M
Rockwell Medical RMTI:US USD -3467000 774K
Sientra SIEN:US USD -11013000 3.27M
Staar Surgical STAA:US USD 2.35M 12.44M
Thermo Fisher Scientific TMO:US USD 2.77B 166M
Utah Medical Products UTMD:US USD 6.87M 52K